(HealthDay)—For some men with prostate cancer, hormonal therapy to beat the disease could be safely cut from three years to half that time, a new clinical trial suggests.
Feb 13, 2013
0
0
For several years, Wilmot Cancer Institute scientist Catherine Ovitt, Ph.D., has been investigating ways to protect and regenerate the salivary gland, which can be damaged during radiation treatment for head and neck cancer. ...
Aug 8, 2018
0
0
(HealthDay)—Unituxin (dinutuximab) has been approved by the U.S. Food and Drug Administration to treat children with high-risk neuroblastoma, a rare cancer that most often affects children aged five and under.
Mar 11, 2015
0
6
A new, minimally invasive treatment that tears microscopic holes in tumors without harming healthy tissue is a promising treatment for challenging cancers, suggests a preliminary study being presented at the Society of Interventional ...
Apr 14, 2013
0
0
Breast cancer is the most common cancer in women. The development of breast cancer often originates from epithelial cells in the mammary gland—the very cells that specialize in milk production during and after pregnancy.
Jan 16, 2024
0
20
Only 20 per cent of men over 50 would opt for surgical treatment if faced with localised prostate cancer, according to a study by Plymouth University.
Mar 14, 2016
0
0
The mammary gland is a complex tissue comprising a variety of cell types. Its proper functioning is crucial for the health of the breast. Among the numerous factors regulating cell homeostasis in the mammary gland, transcription ...
May 16, 2024
0
1
An international team of scientists, including those at the Translational Genomic Research Institute (TGen), have discovered new avenues of potential treatments for a rare and deadly cancer known as Adrenocortical Carcinoma, ...
May 10, 2016
0
3
One of the key questions in stem cell and cancer biology is to understand the cellular hierarchy governing tissue development and maintenance and the cancer cell of origin. In a study published in Cell Reports, researchers ...
Aug 16, 2017
0
0
Cancer onset prevention is considered to be the most important and cost-effective long-term measure for cancer prevention. However, since the molecular mechanisms by which premalignant lesions and very early cancers begin ...
Nov 8, 2021
0
35
